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Introduction
　Sebaceous carcinoma (SC), which originates from seba-
ceous gland cells, is a relatively rare tumor that comprises 
1% of all eye lid tumors.1 Although its clinical behavior is 
aggressive, SC is sometimes misdiagnosed as blepharocon-
junctivitis or a chalazion at the initial stage. Surgical exci-
sion is performed as the primary treatment for SC. The fact 
that SC often exhibits intraepithelial spreading or skip le-
sions makes it difficult to evaluate the surgical margin. Due 
to the rarity of the condition, no generalized strategy has yet 
been established to treat advanced cases. 
　The human epidermal growth factor receptor 2 (HER-2) 
proto-oncogene plays an important role in the development 
and progression of breast and gastric cancer originating from 
gland cells. Monitoring of the HER-2 status was performed 
initially in breast cancer, and the expression of HER-2 is 
now routinely used as a prognostic factor. However, to our 
knowledge, the HER-2 status of SC in the head and neck 
region has not been investigated. We herein report two cases 
of SC in the nasal cavity that displayed unique clinical fea-
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canthus of the eyelid. Sixteen months after the initial treatment, the second patient presented with a large mass in the right 
nasal cavity.
　Results: The wide intraepithelial spread of SC over 30 mm from the initial surgical margin was beyond our expectations. The 
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Case Report
　Case 1. A 61-year-old female was referred with a one-year 
history of a mass in the left medial canthus of the eyelid. She 
had received primary treatment for SC of the eyelid from a 
dermatologist seven years earlier. The initial treatment in-
cluded radiotherapy following local excision of the left up-
per eyelid and skin grafting. Fiberoptic rhinoscopy revealed 
a white submucosal mass in the left inferior nasal meatus. 
The remainder of the nasal cavity and nasopharynx appeared 
normal. A CT scan with contrast demonstrated a mass in the 
left orbit extending into the ipsilateral nasolacrimal duct 
with slight enhancement (Figure 1 A). A CT scan with con-
trast also demonstrated a mass located close to the ipsilateral 
orbital apex (Figure 1 B). A malignant tumor was highly sus-
pected based on a biopsy of the submucosal mass. We per-
formed left extended maxillectomy, left orbital exenteration 
and reconstructive surgery. The first frozen sections used to 
evaluate the surgical margins revealed positive findings at 
the left choana and right nasal-side surface of the soft palate. 
We performed excision and submitted further slivers of tis-
sue for a frozen section analysis. After performing ten addi-
tional excisions, we finally confirmed a negative surgical 
margin at the right Rosenmüller fossa. The distance from the 
initial macroscopic margin to the final microscopic margin 
was over 30 mm. The histologic features of the tumor were 
consistent with those of SC. Pathologically, the surgical mar-
gin was negative. The patient then underwent concurrent 
chemoradiotherapy (a total dose of 60 Gy with 212 mg of 
cisplatin and 5,625 mg of 5-FU) after the surgery. After three 
years of follow-up, the tumor recurred at the apex of the left 
orbit. The patient remains alive following the administration 
of additional radiotherapy. 
　Case 2. A 77-year-old female was referred with a three-
month history of nasal obstruction. She had received primary 
treatment for SC of the eyelids by a plastic surgeon 16 months 
earlier. The initial treatment had been local excision of the 
right eyelid, right orbital exenteration and reconstructive 
surgery. Her right nasal cavity was completely obstructed by 
a tumor. Fiberoptic rhinoscopy via the left nose revealed the 
posterior edge of the tumor. The remainder of the nasal cavity 
and nasopharynx appeared normal. A serial T1-weighted MRI 
scan with contrast for a follow-up study demonstrated chron-
ological growth of a mass in the right orbit extending into 
the ipsilateral nasolacrimal duct after the initial treatment 
(Figure 2). The tumor was biopsied and diagnosed as a re-
current lesion of SC. We performed right extended maxil-
lectomy and reconstructive surgery. As observed in the first 
case, the first examination of frozen sections of the surgical 
margins revealed positive findings at the margin of the right 
torus tubarius and left nasal-side surface of the soft palate. 
We performed additional excision and submitted the tissue 
for a further examination. After performing six additional 
excisions, we finally confirmed the presence of a negative 
surgical margin at the right side of the nasopharyngeal 
mucosa and left nasal-side surface of the soft palate. The 
distance from the initial macroscopic margin of the tumor 
Figure 1. The Computed tomographic image of case 1. (A) Con-
trast-enhanced coronal computed tomographic image of a mass 
located in the left orbit extending into the ipsilateral nasolacrimal 
duct with slight enhancement (asterisk). (B) A contrast-enhanced 
axial computed tomographic image of a mass located close to the 
ipsilateral orbital apex with slight enhancement (asterisk).
Figure 2. (A) One year before the initial consultation at our institution. Four months after the primary treatment for sebaceous 
carcinoma of the eyelids. No distinct masses were detected. (B) Six months before the initial consultation at our institution. A 
small mass was detected at the inferior nasal meatus (asterisk). (C) At the time of the initial consultation at our institution. The 
right maxillary sinus was filled with a recurrent tumor (asterisk).
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to the final microscopic margin was over 20 mm. The histo-
logic features of the tumor were consistent with those of SC 
(Figure 3). Although we confirmed the presence of a nega-
tive surgical margin on the frozen sections, the surgical mar-
gin was positive in the cartilage of the right Eustachian tube 
according to the permanent pathological section. Adjuvant 
chemoradiotherapy was refused by the patient. After 14 
months of follow-up, the patient died of distant metastasis.
Results of immunohistochemistry (HER-2)
　No immunoreaction was observed in case 1. However, a 
positive reaction for HER-2 was observed in the tumor cells 
from case 2 (Figure 4).
Discussion
　Extraocular SC is an uncommon malignancy. Since pri-
mary SC of the eyelid is primarily treated by dermatologists, 
plastic surgeons and ophthalmologists, it is sometimes diffi-
cult to make an early diagnosis of recurrence within the na-
sal cavity.
　SC tends to spread within the epithelium (pagetoid inva-
sion)2 and to manifest as skip lesions. In the current cases, 
recurrent SC had spread along the nasolacrimal duct in a 
pagetoid manner. To date, only one case of nasal SC spread-
ing along the nasolacrimal duct has been described in the 
literature.3 As only a small number of nasal SC cases have 
been reported in the literature, the optimal management 
strategy has not yet been established. The extremely exten-
sive intraepithelial spread of SC observed in the current 
cases was beyond our expectations, particularly in the first 
case. The distance from the initial macroscopic margin to the 
final microscopic margin was quite different in each case. To 
date, no related reports have focused on this issue.
　Dogru et al.4 suggested that a surgical margin of at least 5 
mm should be obtained in patients with eyelid SC. However, 
this was not adequate in our cases. Erovic et al.5 reported a 
high rate of positive resection margins in 46 cases of SC. A 
possible explanation for these results is that pagetoid inva-
sion may be more extensive than expected with considerable 
variation among cases.
　With respect to surgical resection, an important point of 
discussion is how to achieve complete resection of the tu-
mor. Preoperative wide margin biopsies may therefore be 
useful for making an accurate clinical assessment of the ex-
tent of the tumor. 
　In the second case, we were unable to achieve a negative 
surgical margin using frozen sections. We hypothesize that 
there may have been a skip lesion close to the surgical mar-
gin, which indicates that performing a preoperative wide 
margin biopsy may not be adequate to evaluate the presence 
of skip lesions in patients with SC. Clinicians should there-
fore keep in mind the existence of skip lesions when per-
forming surgery for SC.
　It is difficult to detect SC that spreads along the nasolacri-
mal duct without manifesting mass lesions using imaging 
modalities. We believe that head and neck surgeons can play 
an important role in detecting the unique recurrent features 
of this tumor earlier by conducting follow-up endoscopic 
studies. In our experience, white submucosal masses should 
be biopsied to confirm recurrence in such cases. In the cur-
rent cases, pagetoid invasion spread toward the nasophar-
ynx. There is no reasonable explanation as to why pagetoid 
Figure 3. Histology of the mucous membrane at the right maxil-
lary sinus revealed intraepithelial pagetoid spread of the sebaceous 
carcinoma in case 2 (H&E; × 200). All densely stained cells with 
a greater nucleus/cytoplasmic (N/C) ratio in the epithelial layer 
are tumor cells.
Figure 4. The findings of HER-2 staining for the tumor. (A) No 
immunostaining for HER-2 was observed in case 1 (x400). (B) 
The dark stained cell membrane was considered to be immunopo-
sitive. Therefore overexpression of HER-2 was observed in more 
than 10% of the tumor cells in case 2 (x400).
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invasion does not spread toward the nares. It was difficult to 
resect the tumors completely in both of the patients reported 
in this study. We suggest that the optimal treatment of SC of 
the nasal cavity can be accomplished by consistently per-
forming preoperative wide margin biopsies and intraopera-
tive examinations of frozen sections and obtaining wide sur-
gical margins of over 20 mm. In addition, since SC is a rare 
but aggressive form of skin cancer, careful observation is 
required after surgery.
　The paucity of clinical samples has precluded the detailed 
immunohistochemical analysis of SC. El Sheikh6 reported 
that two cases of SC of the skin showed immunopositivity 
for HER-2. HER-2 is associated with a poor prognosis in 
some cancers.7 In our case, the first case was immunonega-
tive. However, case 2, who showed aggressive mucosal in-
vasion and a poor prognosis, had a positive reaction for 
HER-2. Because our sample size was so small, we could not 
draw any conclusions regarding whether the expression of 
HER-2 in SC of the head and neck region is associated with 
poor prognosis. However, HER-2-positive SC in the head 
and neck region is likely to exhibit aggressive invasion. A 
further study on the relationship between HER-2 in the head 
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